The Development of Genetic Modification Techniques in Intracellular Parasites and Potential Applications to Microsporidia

PLoS Pathogens

Volumn 11, Issue 12, 2015, Pages

  Reinke, Aaron W ^a   Troemel, Emily R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BACTERIUM TRANSFORMATION; CRYPTOSPORIDIUM; DNA MODIFICATION; GENE FUNCTION; GENE SEQUENCE; GENETIC MANIPULATION; GENOME ANALYSIS; MICROBIAL GENETICS; MICROSPORIDIA; NONHUMAN; PARASITOLOGY; PATHOGENESIS; PLASMODIUM; REVIEW; ANIMAL; GENETIC PROCEDURES; GENETICS; HUMAN; MICROSPORIDIOSIS;

ANIMALS; GENETIC TECHNIQUES; HUMANS; MICROSPORIDA; MICROSPORIDIOSIS;

EID: 84953239920     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005283     Document Type: Review

References (43)

1. Vavra J, Lukes J, Microsporidia and 'the art of living together'. Advances in parasitology. 2013;82:253–319. Epub 2013/04/04. doi: 10.1016/B978-0-12-407706-5.00004–6 23548087.
2. Corradi N, Pombert JF, Farinelli L, Didier ES, Keeling PJ, The complete sequence of the smallest known nuclear genome from the microsporidian Encephalitozoon intestinalis. Nat Commun. 2010;1:77. Epub 2010/09/25. doi: 10.1038/ncomms1082 20865802.
3. Aurrecoechea C, Barreto A, Brestelli J, Brunk BP, Cade S, Doherty R, et al. EuPathDB: the eukaryotic pathogen database. Nucleic Acids Res. 2013;41(Database issue):D684–91. Epub 2012/11/24. doi: 10.1093/nar/gks1113 23175615; PubMed Central PMCID: PMC3531183.
4. Aurrecoechea C, Barreto A, Brestelli J, Brunk BP, Caler EV, Fischer S, et al. AmoebaDB and MicrosporidiaDB: functional genomic resources for Amoebozoa and Microsporidia species. Nucleic Acids Res. 2011;39(Database issue):D612–9. Epub 2010/10/27. doi: 10.1093/nar/gkq1006 20974635; PubMed Central PMCID: PMC3013638.
5. Cuomo CA, Desjardins CA, Bakowski MA, Goldberg J, Ma AT, Becnel JJ, et al. Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth. Genome Res. 2012;22(12):2478–88. Epub 2012/07/21. doi: 10.1101/gr.142802.112 22813931; PubMed Central PMCID: PMC3514677.
6. Grisdale CJ, Bowers LC, Didier ES, Fast NM, Transcriptome analysis of the parasite Encephalitozoon cuniculi: an in-depth examination of pre-mRNA splicing in a reduced eukaryote. BMC Genomics. 2013;14:207. Epub 2013/03/30. doi: 10.1186/1471-2164-14-207 23537046; PubMed Central PMCID: PMC3629993.
7. Desjardins CA, Sanscrainte ND, Goldberg JM, Heiman D, Young S, Zeng Q, et al. Contrasting host-pathogen interactions and genome evolution in two generalist and specialist microsporidian pathogens of mosquitoes. Nat Commun. 2015;6:7121. Epub 2015/05/15. doi: 10.1038/ncomms8121 25968466; PubMed Central PMCID: PMC4435813.
8. Sternberg SH, Doudna JA, Expanding the Biologist's Toolkit with CRISPR-Cas9. Mol Cell. 2015;58(4):568–74. Epub 2015/05/23. doi: 10.1016/j.molcel.2015.02.032 26000842.
9. Soldati D, Boothroyd JC, Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science. 1993;260(5106):349–52. Epub 1993/04/16. 8469986.
10. Donald RG, Roos DS, Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(24):11703–7. Epub 1993/12/15. 8265612; PubMed Central PMCID: PMC48052.
11. Kim K, Soldati D, Boothroyd JC, Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science. 1993;262(5135):911–4. Epub 1993/11/05. 8235614.
12. Messina M, Niesman I, Mercier C, Sibley LD, Stable DNA transformation of Toxoplasma gondii using phleomycin selection. Gene. 1995;165(2):213–7. Epub 1995/11/20. 8522178.
13. Sibley LD, Messina M, Niesman IR, Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(12):5508–12. Epub 1994/06/07. 8202518; PubMed Central PMCID: PMC44025.
14. Donald RG, Carter D, Ullman B, Roos DS, Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation. The Journal of biological chemistry. 1996;271(24):14010–9. Epub 1996/06/14. 8662859.
15. Striepen B, He CY, Matrajt M, Soldati D, Roos DS, Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. Molecular and biochemical parasitology. 1998;92(2):325–38. Epub 1998/07/10. 9657336.
16. Black M, Seeber F, Soldati D, Kim K, Boothroyd JC, Restriction enzyme-mediated integration elevates transformation frequency and enables co-transfection of Toxoplasma gondii. Molecular and biochemical parasitology. 1995;74(1):55–63. Epub 1995/10/01. 8719245.
17. Fox BA, Ristuccia JG, Gigley JP, Bzik DJ, Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining. Eukaryot Cell. 2009;8(4):520–9. Epub 2009/02/17. doi: 10.1128/EC.00357-08 19218423; PubMed Central PMCID: PMC2669201.
18. Shen B, Brown KM, Lee TD, Sibley LD, Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. mBio. 2014;5(3):e01114–14. Epub 2014/05/16. doi: 10.1128/mBio.01114-14 24825012; PubMed Central PMCID: PMC4030483.
19. Sidik SM, Hackett CG, Tran F, Westwood NJ, Lourido S, Efficient genome engineering of Toxoplasma gondii using CRISPR/Cas9. PLoS ONE. 2014;9(6):e100450. Epub 2014/06/28. doi: 10.1371/journal.pone.0100450 24971596; PubMed Central PMCID: PMC4074098.
20. Wu Y, Sifri CD, Lei HH, Su XZ, Wellems TE, Transfection of Plasmodium falciparum within human red blood cells. Proceedings of the National Academy of Sciences of the United States of America. 1995;92(4):973–7. Epub 1995/02/14. 7862676; PubMed Central PMCID: PMC42619.
21. Kirkman LA, Lawrence EA, Deitsch KW, Malaria parasites utilize both homologous recombination and alternative end joining pathways to maintain genome integrity. Nucleic Acids Res. 2014;42(1):370–9. Epub 2013/10/04. doi: 10.1093/nar/gkt881 24089143; PubMed Central PMCID: PMC3874194.
22. Wu Y, Kirkman LA, Wellems TE, Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(3):1130–4. Epub 1996/02/06. 8577727; PubMed Central PMCID: PMC40043.
23. van Dijk MR, Waters AP, Janse CJ, Stable transfection of malaria parasite blood stages. Science. 1995;268(5215):1358–62. Epub 1995/06/02. 7761856.
24. Sultan AA, Thathy V, Nussenzweig V, Menard R, Green fluorescent protein as a marker in Plasmodium berghei transformation. Infection and immunity. 1999;67(5):2602–6. Epub 1999/05/04. 10225926; PubMed Central PMCID: PMC116009.
25. Wagner JC, Platt RJ, Goldfless SJ, Zhang F, Niles JC, Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum. Nat Methods. 2014;11(9):915–8. Epub 2014/08/12. doi: 10.1038/nmeth.3063 25108687; PubMed Central PMCID: PMC4199390.
26. Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ, Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol. 2014;32(8):819–21. Epub 2014/06/02. doi: 10.1038/nbt.2925 24880488.
27. Vinayak S, Pawlowic MC, Sateriale A, Brooks CF, Studstill CJ, Bar-Peled Y, et al. Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. Nature. 2015;523(7561):477–80. Epub 2015/07/16. doi: 10.1038/nature14651 26176919.
28. Didier PJ, Phillips JN, Kuebler DJ, Nasr M, Brindley PJ, Stovall ME, et al. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo. Antimicrobial agents and chemotherapy. 2006;50(6):2146–55. Epub 2006/05/26. doi: 10.1128/AAC.00020-06 16723577; PubMed Central PMCID: PMC1479127.
29. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM, The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(12):6099–103. Epub 1997/06/10. 9177176; PubMed Central PMCID: PMC21008.
30. Bakowski MA, Desjardins CA, Smelkinson MG, Dunbar TA, Lopez-Moyado IF, Rifkin SA, et al. Ubiquitin-mediated response to microsporidia and virus infection in C. elegans. PLoS Pathog. 2014;10(6):e1004200. Epub 2014/06/20. doi: 10.1371/journal.ppat.1004200 24945527; PubMed Central PMCID: PMC4063957.
31. Lee SC, Heitman J, Ironside JE, Weiss LM, Becnel JJ, Sex and the Microsporidia. In: Microsporidia: Pathogens of Opportunity: Wiley-Blackwell; 2014. p. 231–43.
32. Gill EE, Fast NM, Stripped-down DNA repair in a highly reduced parasite. BMC molecular biology. 2007;8:24. Epub 2007/03/22. doi: 10.1186/1471-2199-8-24 17374165; PubMed Central PMCID: PMC1851970.
33. Deitsch K, Driskill C, Wellems T, Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 2001;29(3):850–3. 11160909; PubMed Central PMCID: PMC30384.
34. Selman M, Sak B, Kvac M, Farinelli L, Weiss LM, Corradi N, Extremely reduced levels of heterozygosity in the vertebrate pathogen Encephalitozoon cuniculi. Eukaryot Cell. 2013;12(4):496–502. doi: 10.1128/EC.00307-12 23376943; PubMed Central PMCID: PMC3623448.
35. Bakowski MA, Priest M, Young S, Cuomo CA, Troemel ER, Genome Sequence of the Microsporidian Species Nematocida sp1 Strain ERTm6 (ATCC PRA-372). Genome Announc. 2014;2(5). doi: 10.1128/genomeA.00905-14 25237020; PubMed Central PMCID: PMC4172269.
36. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013;153(4):910–8. doi: 10.1016/j.cell.2013.04.025 23643243; PubMed Central PMCID: PMC3969854.
37. Gantz VM, Bier E, Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science. 2015;348(6233):442–4. doi: 10.1126/science.aaa5945 25908821.
38. Olmedo-Monfil V, Cortes-Penagos C, Herrera-Estrella A, Three decades of fungal transformation: key concepts and applications. Methods in molecular biology. 2004;267:297–313. doi: 10.1385/1-59259-774-2:297 15269433.
39. Chun CD, Madhani HD, Applying genetics and molecular biology to the study of the human pathogen Cryptococcus neoformans. Methods in enzymology. 2010;470:797–831. doi: 10.1016/S0076-6879(10)70033-1 20946836; PubMed Central PMCID: PMC3611884.
40. Beare PA, Sandoz KM, Omsland A, Rockey DD, Heinzen RA, Advances in genetic manipulation of obligate intracellular bacterial pathogens. Front Microbiol. 2011;2:97. doi: 10.3389/fmicb.2011.00097 21833334; PubMed Central PMCID: PMC3153054.
41. Wood DO, Wood RR, Tucker AM, Genetic systems for studying obligate intracellular pathogens: an update. Current opinion in microbiology. 2014;17:11–6. doi: 10.1016/j.mib.2013.10.006 24581687; PubMed Central PMCID: PMC3942670.
42. Shaner NC, Lambert GG, Chammas A, Ni Y, Cranfill PJ, Baird MA, et al. A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat Methods. 2013;10(5):407–9. doi: 10.1038/nmeth.2413 23524392; PubMed Central PMCID: PMC3811051.
43. Lee S, Lim WA, Thorn KS, Improved blue, green, and red fluorescent protein tagging vectors for S. cerevisiae. PLoS ONE. 2013;8(7):e67902. doi: 10.1371/journal.pone.0067902 23844123; PubMed Central PMCID: PMC3699464.